Your SlideShare is downloading. ×
PowerPoint Presentation
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

PowerPoint Presentation

837
views

Published on


0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
837
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
32
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Managing Seizure Patients in the Emergency Department James Wheless, MD Director, Texas Comprehensive Epilepsy Program University of Texas - Houston
  • 2. Question #1: When is an antiepileptic drug (AED) loading dose necessary?
  • 3. Acute Seizures That Need a Loading Dose
    • Seizures secondary to partial compliance
    • Dose (mg) = weight (Kg) x V D (L/Kg) x D Cp (mg/dL)
    • Seizures with a high rate of recurrence
    • (Some seizures are like potato chips:
    • you can never have just one!!)
    Myoclonic, tonic, absence, atonic
  • 4. Acute Seizures That Need a Loading Dose
    • Progressive neurologic disease
    • Acute symptomatic seizures
    • New onset adult seizures
    • Status epilepticus – depends on etiology
    • ( febrile status epilepticus- probably not)
    • Neonatal seizures
  • 5. Acute Seizures That May Not Need a Loading Dose
    • New onset pediatric complex partial,
    • generalized tonic-clonic seizures
    • ( not status epilepticus)
    • Febrile seizures
    • Some acute symptomatic seizures
    • (i.e., decreased blood sugar)
  • 6. Question #2: What medications are best for an AED loading dose?
  • 7.  
  • 8. Question #3: What is the empirical therapy for acute seizures?
  • 9.  
  • 10.  
  • 11.  
  • 12.  
  • 13.  
  • 14.  
  • 15.  
  • 16.  
  • 17.  
  • 18. Question #4: What antiepileptic drugs are useful for nonconvulsive status epilepticus (SE) (altered mental status presenting as SE)?
  • 19.  
  • 20.  
  • 21.  
  • 22.  
  • 23.  
  • 24.
    • Question #5:
    • When do we use:
    • Fosphenytoin?
    • Phenobarbital?
    • IV Valproate?
  • 25.  
  • 26.  
  • 27.  
  • 28.  
  • 29.  
  • 30.  
  • 31.  
  • 32.  
  • 33.  
  • 34.  
  • 35.  
  • 36.  
  • 37.  
  • 38.  
  • 39. Question #6: What parenteral medications can be given if no IV access is available?
  • 40.  
  • 41.  
  • 42.  
  • 43. Development of a Rapid- Onset Intranasal Delivery of Diazepam
    • Effective nasal delivery volume < 300ml (150ml/nostril)
    • Ethyl laurate-based microemulsion developed
    • Diazepam solubility in microemulsion is 41 mg/ml
    • Bioavailability = ½ of IV diazepam
    • Maximum plasma concentration reached in 2-3 min.
    • Li L et al (B M Squibb), Int. J. Pharm., 2002, 237 (1-2): 77-85
  • 44. Pediatric Status Epilepticus: IM Midazolam
    • Children (N = 48) 4 mo.- 14 yrs. (69 episodes)
    • Midazolam 0.2 mg/Kg IM in ER
    • 35 seizures 10-20 min., 34 > 20 min. duration at
    • presentation in ER
    • Results:
      • 57 episodes (83%) stopped in 1-5 min.
      • 7 episodes (10%) stopped in 5-10 min.
      • Lahat E et al, Pediatric Neurology, 1992; 8: 215-216
  • 45.  
  • 46. Chaimberlain JM, Pediatric Emerg. Care, 1997;13, 92
  • 47.  
  • 48.  
  • 49.  
  • 50. Pharmacokinetics of Midazolam by Intranasal (IN) Administration
    • Subjects (6) had irritation, general discomfort
    • Suggested doses for status epilepticus:
    • - children 0.2 mg/Kg IN
    • - adults 5-10 mg IN
    • Parenteral midazolam 5 mg/ml
    • Mean peak plasma conc. reached 14 min. ( + 5)
    • Mean bioavailability 0.83 ( + 0.19) IN
    • Knoester PD et al, Br. J. Clin. Pharmacol., 2002; 53(5): 501-507
  • 51.  
  • 52.  
  • 53.  
  • 54.  
  • 55.  
  • 56. Parenteral Formulation to Avoid for IM Use
    • Depacon (IV Valproate)
    • IM – muscle necrosis
    • Phenytoin
    • IM – muscle necrosis
    • Phenobarbital
    • slow onset
  • 57.  
  • 58. Question #7: How do pediatric and adult cases of acute seizures and status epilepticus differ?
  • 59.  
  • 60.  
  • 61.  
  • 62.  
  • 63.  
  • 64.  
  • 65.